Co-Diagnostics, Inc. Deferred Tax Assets, Tax Credit Carryforwards, Research
Co-Diagnostics, Inc. (CODX) had Deferred Tax Assets, Tax Credit Carryforwards, Research of $3.30 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch · last filed 2026-03-31
- 2025-12-31: Deferred Tax Assets, Tax Credit Carryforwards, Research $3.30M.
- 2024-12-31: Deferred Tax Assets, Tax Credit Carryforwards, Research $2.31M.
- 2023-12-31: Deferred Tax Assets, Tax Credit Carryforwards, Research $1.69M.
- 2019-12-31: Deferred Tax Assets, Tax Credit Carryforwards, Research $1.60K.
| Period end | Deferred Tax Assets, Tax Credit Carryforwards, Research |
|---|---|
| 2025-12-31 | $3.30M 10-K · filed 2026-03-31 |
| 2024-12-31 | $2.31M 10-K · filed 2026-03-31 |
| 2023-12-31 | $1.69M 10-K · filed 2025-03-27 |
| 2019-12-31 | $1.60K 10-K · filed 2021-03-25 |
| 2018-12-31 | $1.60K 10-K · filed 2020-03-30 |
| 2017-12-31 | $1.60K 10-K · filed 2019-04-01 |
| 2016-12-31 | $2.40K 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |